Cellular Dynamics (Madison, WI) commercial-stage biotechnology company focused on the manufacturer of human induced pluripotent stem cells and tissue cells, closed a $30M Series C financing. Participants have included Tactics II Stem Cell Ventures, Equity Group Investments, Sixth Floor Investors and G Force Investments.

Mithridion (Madison, WI) a clinical-stage biopharmaceutical company focused on CNS disorders with an initial focus on Alzheimer’s and schizophrenia, closed a $1.2M Series C financing. Participants include, Venture Investors, the State of Wisconsin Investment Board and Rocket Venture Fund.

Virent Energy Systems (Madison, WI) a development-stage biofuels company focused on catalytically transforming soluble biomass into hydrocarbons, closed a $46.4M Series C financing. Participants include Shell and Cargill Ventures.

Cellular Dynamics (Madison, WA) a commercial-stage supplier of cardiomyocytes derived from, closed a $40.6M Series B financing. Participants include Tactics II Stem Cell Ventures, Equity Group Investments and Sixth Floor Investors.

Rapid Diagnostek (Hudson, WI) a development-stage medical device company focused on vitro diagnostics using radio frequency phase shift technology for virus detection in fluid samples, closed a $4M Series B financing. Participants include Peak Ridge Capital.

ProCertus BioPharm (Madison, WI) a clinical-stage developer of treatments to combat the side effects of chemotherapy and radiotherapy, e.g. alopecia, dermatitis and oral mucositis, closed a $2.1M Series A. Participants include Novartis Venture Fund and Venture Investors.

Mithridion (Madison, WI) an early-stage drug development company focused on central nervous system disorders, including Alzheimer’s disease, closed a $2.9M Series B financing. Participants include Venture Investors, Rocket Ventures, The State of Wisconsin Investment Board and Wisconsin Investment Partners.